This time on the BioRevolution podcast Andreas Horchler and Louise von Stechow discuss science itself.
While recent surveys show persistently high trust in science worldwide, certain scientific topics have become the subject of intense societal and political debate. This politicization of science puts scientists in a difficult position when they are trying to argue based on facts.
The value of facts and evidence-based science seems to be increasingly questioned by those in power and by those in control of assets. If those who make laws and regulate science don’t see evidence and consensus as reliable resources anymore, what will become of progress in biomedicine, which feeds innovation in biotech, pharma, and medicine?
Content and Editing:
Louise von Stechow and Andreas Horchler
Disclaimer:
Louise von Stechow & Andreas Horchler and their guests express their personal opinions, which are founded on research on the respective topics, but do not claim to give medical, investment or even life advice in the podcast.
Learn more about the future of biotech in our podcasts and keynotes. Contact us here:
scientific communication: https://science-tales.com/
Podcasts: https://www.podcon.de/
Keynotes: https://www.zukunftsinstitut.de/louise-von-stechow
Image:
Marc Teufel
Further reading
https://nsf-gov-resources.nsf.gov/2023-04/EndlessFrontier75th_w.pdf
https://www.nature.com/articles/s41562-024-02090-5
https://www.nature.com/articles/s41599-024-03909-2
https://www.pewresearch.org/science/2024/11/14/public-trust-in-scientists-and-views-on-their-role-in-policymaking/?utm_source=chatgpt.com
https://www.nature.com/articles/d41586-025-00525-1
https://pmc.ncbi.nlm.nih.gov/articles/PMC8793038/
https://www.wissenschaftskommunikation.de/wie-lange-vertraut-man-uns-noch-83325/
https://www.nopatientleftbehind.org/defending-the-foundation-of-american-science
https://theweek.com/science/distrust-science-politics-2024-public-trust-vaccines-milk-pandemic
https://pmc.ncbi.nlm.nih.gov/articles/PMC11004618/
https://www.nature.com/articles/d41586-024-00238-x
https://www.forbes.com/sites/innovationrx/2025/02/19/innovationrx-recursion-launches-fund-for-biotech-startups-hit-by-nih-funding-cuts/